BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 38292478)

  • 21. A potential area of use for immune checkpoint inhibitors: Targeting bone marrow microenvironment in acute myeloid leukemia.
    Aru B; Pehlivanoğlu C; Dal Z; Dereli-Çalışkan NN; Gürlü E; Yanıkkaya-Demirel G
    Front Immunol; 2023; 14():1108200. PubMed ID: 36742324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating exosomes carrying an immunosuppressive cargo interfere with cellular immunotherapy in acute myeloid leukemia.
    Hong CS; Sharma P; Yerneni SS; Simms P; Jackson EK; Whiteside TL; Boyiadzis M
    Sci Rep; 2017 Oct; 7(1):14684. PubMed ID: 29089618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allogeneic hematopoietic stem cell transplant overcomes poor prognosis of acute myeloid leukemia with myelodysplasia-related changes.
    Ikegawa S; Doki N; Kurosawa S; Yamaguchi T; Sakaguchi M; Harada K; Yamamoto K; Hino Y; Shingai N; Senoo Y; Watanabe K; Igarashi A; Najima Y; Kobayashi T; Kakihana K; Sakamaki H; Ohashi K
    Leuk Lymphoma; 2016; 57(1):76-80. PubMed ID: 26084204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human acute myeloid leukemia blast-derived exosomes in patient-derived xenograft mice mediate immune suppression.
    Hong CS; Danet-Desnoyers G; Shan X; Sharma P; Whiteside TL; Boyiadzis M
    Exp Hematol; 2019 Aug; 76():60-66.e2. PubMed ID: 31369790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exosomes from bone marrow mesenchymal stem cells decrease chemosensitivity of acute myeloid leukemia cells via delivering miR-10a.
    Wu J; Zhang Y; Li X; Ren J; Chen L; Chen J; Cao Y
    Biochem Biophys Res Commun; 2022 Sep; 622():149-156. PubMed ID: 35863089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNAs and exosomes: promising new biomarkers in acute myeloid leukemias?
    Araújo HV; Sakamoto LHT; Bacal NS; Epelman S; Real JM
    Einstein (Sao Paulo); 2022; 20():eRB5954. PubMed ID: 35303052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Remodeling of Bone Marrow Niches and Roles of Exosomes in Leukemia.
    Yamaguchi T; Kawamoto E; Gaowa A; Park EJ; Shimaoka M
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33668652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The implication of lncRNA expression pattern and potential function of lncRNA RP4-576H24.2 in acute myeloid leukemia.
    Zheng J; Song Y; Li Z; Tang A; Fei Y; He W
    Cancer Med; 2019 Dec; 8(17):7143-7160. PubMed ID: 31568697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute myeloid leukemia cells secrete microRNA-4532-containing exosomes to mediate normal hematopoiesis in hematopoietic stem cells by activating the LDOC1-dependent STAT3 signaling pathway.
    Zhao C; Du F; Zhao Y; Wang S; Qi L
    Stem Cell Res Ther; 2019 Dec; 10(1):384. PubMed ID: 31842997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coordinate regulation of residual bone marrow function by paracrine trafficking of AML exosomes.
    Huan J; Hornick NI; Goloviznina NA; Kamimae-Lanning AN; David LL; Wilmarth PA; Mori T; Chevillet JR; Narla A; Roberts CT; Loriaux MM; Chang BH; Kurre P
    Leukemia; 2015 Dec; 29(12):2285-95. PubMed ID: 26108689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of bone marrow microenvironment (BMM) cells in acute myeloid leukemia (AML) progression: immune checkpoints, metabolic checkpoints, and signaling pathways.
    Bakhtiyari M; Liaghat M; Aziziyan F; Shapourian H; Yahyazadeh S; Alipour M; Shahveh S; Maleki-Sheikhabadi F; Halimi H; Forghaniesfidvajani R; Zalpoor H; Nabi-Afjadi M; Pornour M
    Cell Commun Signal; 2023 Sep; 21(1):252. PubMed ID: 37735675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wilms' tumor gene 1 is an independent prognostic factor for pediatric acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation.
    Deng DX; Wen JJ; Cheng YF; Zhang XH; Xu LP; Wang Y; Yan CH; Chen YH; Chen H; Han W; Wang FR; Wang JZ; Qin YZ; Liu KY; Huang XJ; Zhao XS; Mo XD
    BMC Cancer; 2021 Mar; 21(1):292. PubMed ID: 33740924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pathobiology of acute myeloid leukemia].
    Christ O; Feuring-Buske M; Hiddemann W; Buske C
    Med Klin (Munich); 2007 Apr; 102(4):290-5. PubMed ID: 17426932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exosome-shuttled FTO from BM-MSCs contributes to cancer malignancy and chemoresistance in acute myeloid leukemia by inducing m6A-demethylation: A nano-based investigation.
    Kou R; Li T; Fu C; Jiang D; Wang Y; Meng J; Zhong R; Liang C; Dong M
    Environ Res; 2024 Mar; 244():117783. PubMed ID: 38048862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone Marrow Microenvironment as a Source of New Drug Targets for the Treatment of Acute Myeloid Leukaemia.
    Skelding KA; Barry DL; Theron DZ; Lincz LF
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An immune-related gene prognostic index for acute myeloid leukemia associated with regulatory T cells infiltration.
    Xie Q; Tang Z; Liang X; Shi Z; Yao Y; Huang X; Zhu S; Wu M; Li J; Zhao W; Liu Z
    Hematology; 2022 Dec; 27(1):1088-1100. PubMed ID: 36102723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in multipotent mesenchymal stromal cells from the bone marrow of acute myeloid leukemia patients at diagnosis and during treatment.
    Shipounova IN; Petinati NA; Bigildeev AE; Sorokina TV; Kuzmina LA; Parovichnikova EN; Savchenko VG
    Leuk Lymphoma; 2019 Aug; 60(8):2042-2049. PubMed ID: 30668205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relapse of acute myeloid leukemia after allogeneic stem cell transplantation: immune escape mechanisms and current implications for therapy.
    Sauerer T; Velázquez GF; Schmid C
    Mol Cancer; 2023 Nov; 22(1):180. PubMed ID: 37951964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Micro-RNA Profiling of Exosomes from Marrow-Derived Mesenchymal Stromal Cells in Patients with Acute Myeloid Leukemia: Implications in Leukemogenesis.
    Barrera-Ramirez J; Lavoie JR; Maganti HB; Stanford WL; Ito C; Sabloff M; Brand M; Rosu-Myles M; Le Y; Allan DS
    Stem Cell Rev Rep; 2017 Dec; 13(6):817-825. PubMed ID: 28918518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Niche-directed therapy in acute myeloid leukemia: optimization of stem cell competition for niche occupancy.
    Patel SA; Dalela D; Fan AC; Lloyd MR; Zhang TY
    Leuk Lymphoma; 2022 Jan; 63(1):10-18. PubMed ID: 34407733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.